On Tuesday morning, the US Food and Drug Administration and the Centers for Disease Control and Prevention issued a release acknowledging an extremely rare clotting disorder was associated with the use of the Johnson & Johnson COVID vaccine. The problem is actually less than a one-in-a-million issue; in data from the US, where 6.8 million doses of this vaccine have been used, there have only been six instances of the clotting problem detected. Because the clots call for an unusual treatment, however, the organizations are calling for a pause in administering the shot. This will provide them with time to ensure the medical community is aware of the appropriate treatment. This is not the first vaccine to create extremely rare clotting issues. They’ve also been seen following use of the AstraZeneca vaccine . The problem appears to be caused by the harmless virus (an Adenovirus) that carries a single gene from SARS-CoV-2 in order to elicit an immune response. The leading hypothesis to explain this is that, in very rare cases, the Adenovirus triggers an immune response to factors found on the surface of platelets, which are an essential part of the clotting process. This activates platelets, causing clots, and… Read full this story
- Three Covid vaccine developers report promising initial results from human trials
- Exclusive: EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags - sources
- U.S. orders up to 600 million doses of Pfizer, BioNTech Covid vaccine
- Oxford-AstraZeneca covid vaccine study shows dual immune action
- 'We will price Covid vaccine below Rs 1,000'
- COVID vaccine execs hyped vague data to cash in $90M in stock, watchdog says
- Ray of light enters dark Covid tunnel
- Oxford’s Covid-19 vaccine candidate is safe, early results show
- Experimental Coronavirus Vaccines Continue to Show Promise in Human Trials
- Coronavirus latest: UK phase 2 vaccine trial shows promise
J&J COVID vaccine use paused due to one-in-a-million complication have 297 words, post on arstechnica.com at April 13, 2021. This is cached page on Technology Breaking News. If you want remove this page, please contact us.